SIETES :: 92559 citas

Resultados de la búsqueda por EFECTIVIDAD REFINAR BÚSQUEDA

1.

Baillargeon J, Kuo YF, Westra JR, Urban RJ, Goodwin JS. Testosterone prescribing in the United States, 2002-2016. JAMA 2018;319:10 de julio. [Ref.ID 102792]

2.

Kitchlu A, Shapiro J, Amir E, Garg AX, Kim J, Wald R, Harel Z. Representation of patients with chronic kidney disease in trials of cancer therapy. JAMA 2018;319:19 de junio. [Ref.ID 102790]

3.

Zash R, Makhema J, Shapiro RL. Neural-tube defects with dolutegravir treatment from the time of conception. N Engl J Med 2018:24 de julio. [Ref.ID 102748]

4.

Rasmussen SA, Barfield W, Honein MA. Protecting mothers and babies — A delicate balancing act. N Engl J Med 2018:24 de julio. [Ref.ID 102747]

5.

Hopcroft K. Effectiveness of antidepressants - should we rethink treatment duration?. BMJ 2018;361:24 de abril. [Ref.ID 102576]

6.

Garattini S, Bertele V. Benefits, benefits, once more benefits... with no risk? Stop overlooking the harms of medicines. Eur J Clin Pharmacol 2018;74:marzo. [Ref.ID 102550]

7.

Wise J. Trivalent flu vaccine won’t protect against influenza B strain predominantly circulating. BMJ 2018;360:k78. [Ref.ID 102448]

8.

Go AS, Singer DE, Toh S, Cheetham TC, Reichman ME, Graham DJ, Southworth MR, Zhang R, Izem R, Goulding MR, Houstoun M, Mott K, Sung SH, Gagne JJ. Outcomes of dabigatran and warfarin for atrial fibrillation in contemporary practice: a retrospective cohort study. Ann Intern Med 2017;167:845-54. [Ref.ID 102196]

9.

Anónimo. Health officials predict rough flu season, point to potentially less effective vaccine. DIA Daily 2017:17. [Ref.ID 102161]

10.

Fanning L, Ilomäki J, Bell JS, Darzinš P. The representativeness of direct oral anticoagulant clinical trials to hospitalized patients with atrial fibrillation. Eur J Clin Pharmacol 2017;73:1427-36. [Ref.ID 102129]

11.

Naci H, Smalley KR, Kesselheim AS. Characteristics of preapproval and postapproval studies for drugs granted accelerated approval by the US Food and Drug Administration. JAMA 2017;318:626-36. [Ref.ID 102056]

12.

Anónimo. NICE considers eliminating Sanofi, Ipsen thyroid cancer drugs From Cancer Drug Fund. DIA Daily 2017:2. [Ref.ID 102033]

13.

Mazlan-Kepli W, Macisaac RL, Walters M, Bath PMW, Dawson J, on behalf of the VISTA Collaborators. Interruption to antiplatelet therapy early after acute ischaemic stroke: a nested case–control study. Br J Clin Pharmacol 2017;83:2045-55. [Ref.ID 102030]

14.

Gieling EM, van den Ham HA, van Onzenoort H, Bos J, Kramers C, de Boer A, de Vries F, Burden AM. Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol 2017;83:1844-59. [Ref.ID 102014]

15.

Lehto M, Niiranen J, Korhonen P, Mehtälä J, Khanfir H, Hoti F, Lassila R, Raatikainen P. Quality of warfarin therapy and risk of stroke, bleeding, and mortality among patients with atrial fibrillation: results from the nationwide FinWAF Registry. Pharmacoepidemiol Drug Saf 2017;26:657-65. [Ref.ID 101963]

16.

Perreault S, de Denus S, White M, White-Guay B, Bouvier M, Dorais M, Dubé M-P, Rouleau J-L, Tardif J-C, Jenna S, Haibe-Kains B, Leduc R, Deblois D. Older adults with heart failure treated with carvedilol, bisoprolol, or metoprolol tartrate: risk of mortality. Pharmacoepidemiol Drug Saf 2017;26:81-90. [Ref.ID 101948]

17.

Hawkes N. Are new hepatitis C drugs all they’re cracked up to be?. BMJ 2017;357:j2961. [Ref.ID 101659]

18.

Schoenfeld AJ, Redberg RF. The value of using registries to evaluate randomized clinical trial study populations. JAMA Intern Med 2017;177:889. [Ref.ID 101623]

19.

Maddox TM, Tang F, Downs JR, Masoudi FA, Virani SS, Daugherty SL, Rumsfeld JS. Applicability of the IMPROVE-IT trial to current patients with acute coronary syndrome: an NCDR research to practice project. JAMA Intern Med 2017;177:887-9. [Ref.ID 101622]

20.

Mancia G. Should blood pressure reduction be aggressive in patients with hypertension and coronary artery disease?. Lancet 2016;388:2061-2. [Ref.ID 100695]